[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Ljudmila |
| 2. | Perekonnanimi | Miljuhhina |
| 3. | Töökoht | Tervise Arengu Instituut |
| 4. | Ametikoht | Teadur |
| 5. | Sünniaeg | 16.12.1947 (päev.kuu.aasta) |
| 6. | Haridus | Leningradi Ülikool, bioloogia teaduskond, bioloog-histoloog |
| 7. | Teenistuskäik | 1976-1978 - Eksperimentaalse ja Kliinilise Meditsiini Instituut (EKMI), kôrghar. vanemlaborant 1978-1990 - EKMI, nooremteadur 1990 - EKMI, teadur 2003 TAI, teadur |
| 8. | Teaduskraad | MSc |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Leningradi Ülikool |
| 10. | Tunnustused | - |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
- |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Kasvaja immunoloogia, immunohistokeemia |
| 14. | Jooksvad grandid | |
| 15. | Teaduspublikatsioonid |
Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Sljapnikova L. IgG immune response to tumor-associated carbonhydrate antigenes (TF, Tn, aGal) in patients with brest cancer: impact of neoadjuvant chemiotherapy and relation to the survival. Experimental Oncology 2005,27, 2, 136-140 Kurtenkov, O., Klaamas, K., Sergeyev, B., Chuzmarov, V., Miljukhina, L., & Shljapnikova, L. Better Survival of Helicobacter Pylori Infected Patients With Early Gastric Cancer Is Related to a Higher Level of Thomsen- Friedenreich Antigen-Specific Antibodies. Immunological Investigations 2003, 32(1-2), 83-93. Klaamas, K., Kurtenkov, O., Brjalin, V., Miljukhina, L., Shljapnikova, L., & Engstrand, L. Enhanced Humoral Immune Response to Tumor-Associated T Glycotope (Gal Beta 1,3-Gainac) in Helicobacter Pylori-Infected Patients With Gastric Cancer and Non-Tumor Gastric Diseases. Experimental Oncology 2002, 24(1), 38-44. Klaamas, K., Kurtenkov, O., Rittenhouse-Olson, K., Brjalin, V., Miljukhina, L., Shljapnikova, L., & Engstrand, L. Expression of Tumor-Associated Thomsen-Friedenreich Antigen (T Ag) in Helicobacter Pylori and Modulation of T Ag Specific Immune Response in Infected Individuals. Immunological Investigations 2002, 31(3-4), 191-204 Kurtenkov, O., Klaamas, K., Miljukhina, L., Shljapnikova, L., Ellamaa, M., Bovin, N., & Wadstrom, T. Igg Antibodies to Lewis Type 2 Antigen in Serum of H-Pylori- Infected and Noninfected Blood Donors of Different Lewis(a,B) Blood-Group Phenotype. Fems Immunology and Medical Microbiology 1999, 24(2), 227-232. Кurtenkov O., Miljukhina L.,Smorodin J., Klaamas K., Bovin N., Ellamaa M., Chuzmarov V. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors. Relation to Lewis (a,b) histo-blood group phenotype. Acta Oncol. 1999, 38(7):939-943. |
viimati muudetud: 11.08.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Ljudmila |
| 2. | Surname | Miljuhhina |
| 3. | Institution | National Institute for Health Development |
| 4. | Position | Researcher |
| 5. | Date of birth | 16.12.1947 (day.month.year) |
| 6. | Education | Leningrad University, biological faculty, biology-histology |
| 7. | Research and professional experience |
IECM, senior technician 1976-1978 IECM, junior research scientist 1978-1990 IECM, research scientist 1990-2003 National Institute for Health Development, research scientist 2003 |
| 8. | Academic degree | MSc |
| 9. | Dates and sites of earning the degrees |
Leningrad University |
| 10. | Honours/awards | |
| 11. | Research-administrative experience |
|
| 12. | Supervised dissertations | |
| 13. | Current research program | Tumor immunology, immunohistochemistry |
| 14. | Current grant funding | |
| 15. | List of most important publications |
Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Sljapnikova L. IgG immune response to tumor-associated carbonhydrate antigenes (TF, Tn, aGal) in patients with brest cancer: impact of neoadjuvant chemiotherapy and relation to the survival. Experimental Oncology 2005,27, 2, 136-140 Kurtenkov, O., Klaamas, K., Sergeyev, B., Chuzmarov, V., Miljukhina, L., & Shljapnikova, L. Better Survival of Helicobacter Pylori Infected Patients With Early Gastric Cancer Is Related to a Higher Level of Thomsen- Friedenreich Antigen-Specific Antibodies. Immunological Investigations 2003, 32(1-2), 83-93. Klaamas, K., Kurtenkov, O., Brjalin, V., Miljukhina, L., Shljapnikova, L., & Engstrand, L. Enhanced Humoral Immune Response to Tumor-Associated T Glycotope (Gal Beta 1,3-Gainac) in Helicobacter Pylori-Infected Patients With Gastric Cancer and Non-Tumor Gastric Diseases. Experimental Oncology 2002, 24(1), 38-44. Klaamas, K., Kurtenkov, O., Rittenhouse-Olson, K., Brjalin, V., Miljukhina, L., Shljapnikova, L., & Engstrand, L. Expression of Tumor-Associated Thomsen-Friedenreich Antigen (T Ag) in Helicobacter Pylori and Modulation of T Ag Specific Immune Response in Infected Individuals. Immunological Investigations 2002, 31(3-4), 191-204 Kurtenkov, O., Klaamas, K., Miljukhina, L., Shljapnikova, L., Ellamaa, M., Bovin, N., & Wadstrom, T. Igg Antibodies to Lewis Type 2 Antigen in Serum of H-Pylori- Infected and Noninfected Blood Donors of Different Lewis(a,B) Blood-Group Phenotype. Fems Immunology and Medical Microbiology 1999, 24(2), 227-232. Кurtenkov O., Miljukhina L.,Smorodin J., Klaamas K., Bovin N., Ellamaa M., Chuzmarov V. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors. Relation to Lewis (a,b) histo-blood group phenotype. Acta Oncol. 1999, 38(7):939-943. |
last updated: 11.08.2005
[ sulge aken ]